- $3.80m
- $3.98m
- $7.35m
- 58
- 67
- 15
- 44
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.8 | 7.67 | 7.54 | 7.67 | 7.35 |
Cost of Revenue | |||||
Gross Profit | 4.67 | 4 | 3.91 | 3.79 | 4.03 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8.99 | 7.83 | 7 | 7.73 | 7.65 |
Operating Profit | -0.186 | -0.156 | 0.537 | -0.062 | -0.303 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.236 | -0.198 | 0.585 | -0.066 | -0.324 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.236 | -0.198 | 0.585 | -0.066 | -0.324 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.236 | -0.198 | 0.585 | -0.066 | -0.324 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.236 | -0.198 | 0.585 | -0.066 | -0.324 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.022 | -0.017 | -0.001 | -0.051 | -0.028 |